18–20 September 2026 | Hilton Orlando Bonnet Creek, Orlando, Florida

Fibronostics will attend the Florida Gastroenterology Society’s 61st Annual Meeting and the 50th FGS/SGNA Joint Annual Meeting in Orlando. Maria and David Cashio look forward to connecting with gastroenterology professionals and discussing practical approaches to liver assessment.

They will also introduce LIVERFASt™, which uses advanced analytics and commonly available biomarkers to provide fibrosis staging, inflammatory activity grading, and steatosis grading from a single routine blood sample. It offers a more complete view of liver health to help inform further evaluation and clinical pathways for patients with MASLD and MASH.

Attending the meeting? Connect with Maria and David in Orlando to learn more.

10–11 September 2026 | Institut Pasteur, Paris, France

Fibronostics was represented by Brock Smith and Dr Mona Munteanu at the 12th Paris MASH Meeting. The meeting brought together experts from Europe and the United States to exchange perspectives on metabolic liver disease research and clinical care.

For Fibronostics, these conversations reflect an important goal: giving clinicians clearer information to help identify and assess liver disease in people with MASLD and MASH. LIVERFASt™ uses advanced analytics and a routine blood sample to provide insight into fibrosis, inflammatory activity, and steatosis.

Thank you to the organisers and participants for the opportunity to connect and continue the discussion on advancing liver care.